Is Furazolidone Therapy for Helicobacter pylori Effective and Safe?
KeywordsBismuth Proton Pump Inhibitor Pylorus Infection Triple Therapy Esomeprazole
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.Abbas Z, Yakoob J, Abid S, et al. Furazolidone, co-amoxiclav, colloidal bismuth subcitrate, and esomeprazole for patients who failed to eradicate Helicobacter pylori with triple therapy. Dig Dis Sci. 2008 Dec 5 (Epub ahead of print).Google Scholar
- 5.Tatsuta M, Iishi H, Baba M, Taniguchi H. Attenuating effect of the monoamine oxidase inhibitor furazolidone on the anti-carcinogenetic effect of cysteamine on gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer. 1991;48:605–608. doi: 10.1002/ijc.2910480420.PubMedCrossRefGoogle Scholar
- 8.Taghavi SA, Jafari A, Eshraghian A. Efficacy of a new therapeutic regimen versus two routinely prescribed treatments for eradication of Helicobacter pylori: a randomized, double-blind study of doxycycline, co-Amoxiclav, and omeprazole in Iranian Patients. Dig Dis Sci. 2009;54(3):599–603 Jul 2 (Epub ahead of print).Google Scholar
- 11.Park BC, Park SY, Lee JS, Mousa SA, Kim JT, Kwak MK, Kang KW, Lee ES, Choi HG, Yong CS, Kim JA. The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling. Vascul Pharmacol 2009;50(3-4):123–131 Nov 28 (Epub ahead of print).Google Scholar
© Springer Science+Business Media, LLC 2009